CN101182494A - 基因vii型新城疫病毒致弱株a-ndv-vii及其构建方法 - Google Patents
基因vii型新城疫病毒致弱株a-ndv-vii及其构建方法 Download PDFInfo
- Publication number
- CN101182494A CN101182494A CNA2007101318632A CN200710131863A CN101182494A CN 101182494 A CN101182494 A CN 101182494A CN A2007101318632 A CNA2007101318632 A CN A2007101318632A CN 200710131863 A CN200710131863 A CN 200710131863A CN 101182494 A CN101182494 A CN 101182494A
- Authority
- CN
- China
- Prior art keywords
- vii
- ndv
- gene
- strain
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000711404 Avian avulavirus 1 Species 0.000 title claims abstract description 46
- 238000010276 construction Methods 0.000 title claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 title claims description 68
- 230000003313 weakening effect Effects 0.000 title claims description 19
- 241000700605 Viruses Species 0.000 claims abstract description 58
- 239000012634 fragment Substances 0.000 claims abstract description 47
- 241000287828 Gallus gallus Species 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 21
- 101150034814 F gene Proteins 0.000 claims abstract description 17
- 101710121417 Envelope glycoprotein Proteins 0.000 claims abstract description 8
- 239000013612 plasmid Substances 0.000 claims description 40
- 230000008859 change Effects 0.000 claims description 19
- 101150008820 HN gene Proteins 0.000 claims description 18
- 238000013518 transcription Methods 0.000 claims description 15
- 230000035897 transcription Effects 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 12
- 238000005336 cracking Methods 0.000 claims description 12
- 238000011081 inoculation Methods 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 241000271566 Aves Species 0.000 claims description 11
- 206010014599 encephalitis Diseases 0.000 claims description 11
- 108091008146 restriction endonucleases Proteins 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 238000001890 transfection Methods 0.000 claims description 9
- 101100421449 Caenorhabditis elegans shn-1 gene Proteins 0.000 claims description 8
- 210000002257 embryonic structure Anatomy 0.000 claims description 7
- 239000013613 expression plasmid Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 210000003837 chick embryo Anatomy 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 4
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000003636 conditioned culture medium Substances 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 238000001502 gel electrophoresis Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000013326 plasmid cotransfection Methods 0.000 claims description 2
- 229960005486 vaccine Drugs 0.000 abstract description 19
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 10
- 230000002238 attenuated effect Effects 0.000 abstract description 8
- 230000002441 reversible effect Effects 0.000 abstract description 8
- 241000272814 Anser sp. Species 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000035772 mutation Effects 0.000 abstract description 3
- 230000001850 reproductive effect Effects 0.000 abstract description 2
- 101150006005 VII gene Proteins 0.000 abstract 2
- 235000013330 chicken meat Nutrition 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 17
- 208000010359 Newcastle Disease Diseases 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000002299 complementary DNA Substances 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 10
- 239000002574 poison Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 230000001018 virulence Effects 0.000 description 6
- 230000034994 death Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 244000144977 poultry Species 0.000 description 5
- 235000013594 poultry meat Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940028617 conventional vaccine Drugs 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 241001493065 dsRNA viruses Species 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 210000003555 cloaca Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000009361 aviculture Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 102000014303 Amyloid beta-Protein Precursor Human genes 0.000 description 1
- 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 108700004031 HN Proteins 0.000 description 1
- 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010034647 Peristalsis visible Diseases 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000010357 RNA editing Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 230000026279 RNA modification Effects 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000000799 fusogenic effect Effects 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- ZDPUTNZENXVHJC-UUOKFMHZSA-N guanosine 3'-monophosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O ZDPUTNZENXVHJC-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 108010061514 sialic acid receptor Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000007485 viral shedding Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000022534 visible peristalsis Diseases 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
引物编号(扩增片段的位置) | 引物序列(内切酶) |
R1(2849-5223nt)R2(5218-7012nt)R3(7008-9552nt) | 5’-GGGTGAAATGACGCTCAATAAACTCTC-3’5’-ATGGTCTCATCTGTGGCCCGAATACT-3’(Bsa I)5’-ATACGTCTCACAGATCACCTCCCCTGCATTAAC-3’(Bsm B I)5’-GTC4GATCTCTGCAACCGGATAGTATCACA-3’(Bgl II)5’-TCCGTCTCAGATCACTCACACTCACATCAAT-3’(Bsm B I)5’-TCACGACCATCATATCGAAATCTACCATC-3’ |
组别 | 攻毒剂量(ELD50/只) | 攻毒途径 | 发病率发病数/总数 | 死亡率死亡数/总数 | 保护率(%) |
A-NDV-VIIA-NDV-VII-油苗LaSotaPBS | 106106106106 | 滴鼻点眼肌注滴鼻点眼滴鼻点眼 | 0/100/100/1010/10 | 0/100/100/1010/10 | 100100100- |
组别 | SPF鸡病毒分离率(阳性数/总数) | 商品鸡病毒分离率(阳性数/总数) | ||
喉气管 | 泄殖腔 | 喉气管 | 泄殖腔 | |
A-NDV-VIIA-NDV-VII-油苗LaSota | 0/100/101/10 | 0/100/103/10 | 0/100/104/10 | 0/100/102/10 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101318632A CN101182494B (zh) | 2007-09-05 | 2007-09-05 | 基因ⅶ型新城疫病毒致弱株a-ndv-ⅶ及其构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101318632A CN101182494B (zh) | 2007-09-05 | 2007-09-05 | 基因ⅶ型新城疫病毒致弱株a-ndv-ⅶ及其构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101182494A true CN101182494A (zh) | 2008-05-21 |
CN101182494B CN101182494B (zh) | 2010-09-08 |
Family
ID=39447919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101318632A Expired - Fee Related CN101182494B (zh) | 2007-09-05 | 2007-09-05 | 基因ⅶ型新城疫病毒致弱株a-ndv-ⅶ及其构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101182494B (zh) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102268410A (zh) * | 2011-06-17 | 2011-12-07 | 湖北省农业科学院畜牧兽医研究所 | 一株适应幼仓鼠肾传代细胞的新城疫病毒耐热弱毒株及其制备方法和应用 |
CN102533676A (zh) * | 2012-01-04 | 2012-07-04 | 扬州大学 | 新城疫病毒重组疫苗a-ndv-lx/i4及构建方法 |
CN102559607A (zh) * | 2012-01-04 | 2012-07-11 | 扬州大学 | 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统 |
CN102766603A (zh) * | 2012-04-26 | 2012-11-07 | 秦卓明 | 一种鸡新城疫株病毒及其分离方法 |
CN104962526A (zh) * | 2013-09-30 | 2015-10-07 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN107287168A (zh) * | 2016-03-31 | 2017-10-24 | 普莱柯生物工程股份有限公司 | 一种新城疫病毒拯救方法及其应用 |
CN107281479A (zh) * | 2016-03-31 | 2017-10-24 | 普莱柯生物工程股份有限公司 | 一种基因ⅶ型新城疫病毒弱毒株、疫苗组合物及其应用 |
CN107418973A (zh) * | 2017-05-27 | 2017-12-01 | 山东信得科技股份有限公司 | 一种基因vii型新城疫病毒弱毒株的构建方法 |
CN107630008A (zh) * | 2016-07-14 | 2018-01-26 | 中国农业大学 | 基因ⅶ型新城疫病毒标记疫苗株及其应用 |
CN107865965A (zh) * | 2016-09-23 | 2018-04-03 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物、及其制备方法和应用 |
CN108524930A (zh) * | 2018-07-10 | 2018-09-14 | 扬州优邦生物药品有限公司 | 一种小鹅瘟—重组新城疫二联灭活疫苗及其制备方法 |
CN109295095A (zh) * | 2018-10-24 | 2019-02-01 | 扬州大学 | 一种热稳定的基因viii型新城疫弱毒株外源基因表达载体 |
CN109321535A (zh) * | 2018-10-24 | 2019-02-12 | 扬州大学 | 一种热稳定的新城疫病毒弱毒疫苗候选株 |
CN109321534A (zh) * | 2018-11-05 | 2019-02-12 | 扬州大学 | 一种重组基因viii型新城疫病毒弱毒株 |
CN111575247A (zh) * | 2020-05-22 | 2020-08-25 | 浙江鼎持生物制品有限公司 | 一种新城疫嵌合病毒标记疫苗株及其构建方法和应用 |
CN112877361A (zh) * | 2021-02-08 | 2021-06-01 | 青岛海华生物医药技术有限公司 | 一株重组新城疫病毒弱疫苗株及其构建方法 |
WO2021103421A1 (zh) * | 2019-11-27 | 2021-06-03 | 青岛易邦生物工程有限公司 | 基因vii型新城疫病毒弱毒株及其应用 |
CN112961837A (zh) * | 2021-03-01 | 2021-06-15 | 武汉科前生物股份有限公司 | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 |
CN114574452A (zh) * | 2021-12-29 | 2022-06-03 | 扬州大学 | Hn基因易位构建重组新城疫疫苗候选株vii-hnf的方法及用途 |
CN115896111A (zh) * | 2022-10-09 | 2023-04-04 | 青岛大学 | 一种抑制acsl4表达的小干扰rna及其应用 |
-
2007
- 2007-09-05 CN CN2007101318632A patent/CN101182494B/zh not_active Expired - Fee Related
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102268410A (zh) * | 2011-06-17 | 2011-12-07 | 湖北省农业科学院畜牧兽医研究所 | 一株适应幼仓鼠肾传代细胞的新城疫病毒耐热弱毒株及其制备方法和应用 |
CN102533676A (zh) * | 2012-01-04 | 2012-07-04 | 扬州大学 | 新城疫病毒重组疫苗a-ndv-lx/i4及构建方法 |
CN102559607A (zh) * | 2012-01-04 | 2012-07-11 | 扬州大学 | 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统 |
CN102559607B (zh) * | 2012-01-04 | 2013-03-27 | 扬州大学 | 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统 |
CN102533676B (zh) * | 2012-01-04 | 2013-04-17 | 扬州大学 | 新城疫病毒重组疫苗a-ndv-lx/i4及构建方法 |
CN102766603A (zh) * | 2012-04-26 | 2012-11-07 | 秦卓明 | 一种鸡新城疫株病毒及其分离方法 |
CN104974989A (zh) * | 2013-09-30 | 2015-10-14 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN104962527A (zh) * | 2013-09-30 | 2015-10-07 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN104962526B (zh) * | 2013-09-30 | 2018-01-02 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN104962527B (zh) * | 2013-09-30 | 2018-03-16 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN104974989B (zh) * | 2013-09-30 | 2018-03-20 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN104962526A (zh) * | 2013-09-30 | 2015-10-07 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
CN107281479B (zh) * | 2016-03-31 | 2020-12-01 | 普莱柯生物工程股份有限公司 | 一种基因ⅶ型新城疫病毒弱毒株、疫苗组合物及其应用 |
CN107287168A (zh) * | 2016-03-31 | 2017-10-24 | 普莱柯生物工程股份有限公司 | 一种新城疫病毒拯救方法及其应用 |
CN107281479A (zh) * | 2016-03-31 | 2017-10-24 | 普莱柯生物工程股份有限公司 | 一种基因ⅶ型新城疫病毒弱毒株、疫苗组合物及其应用 |
CN107630008B (zh) * | 2016-07-14 | 2021-01-26 | 中国农业大学 | 基因ⅶ型新城疫病毒标记疫苗株及其应用 |
CN107630008A (zh) * | 2016-07-14 | 2018-01-26 | 中国农业大学 | 基因ⅶ型新城疫病毒标记疫苗株及其应用 |
CN107865965A (zh) * | 2016-09-23 | 2018-04-03 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物、及其制备方法和应用 |
CN107865965B (zh) * | 2016-09-23 | 2021-04-06 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物、及其制备方法和应用 |
CN107418973A (zh) * | 2017-05-27 | 2017-12-01 | 山东信得科技股份有限公司 | 一种基因vii型新城疫病毒弱毒株的构建方法 |
CN108524930A (zh) * | 2018-07-10 | 2018-09-14 | 扬州优邦生物药品有限公司 | 一种小鹅瘟—重组新城疫二联灭活疫苗及其制备方法 |
CN109321535A (zh) * | 2018-10-24 | 2019-02-12 | 扬州大学 | 一种热稳定的新城疫病毒弱毒疫苗候选株 |
CN109295095A (zh) * | 2018-10-24 | 2019-02-01 | 扬州大学 | 一种热稳定的基因viii型新城疫弱毒株外源基因表达载体 |
CN109321534A (zh) * | 2018-11-05 | 2019-02-12 | 扬州大学 | 一种重组基因viii型新城疫病毒弱毒株 |
WO2021103421A1 (zh) * | 2019-11-27 | 2021-06-03 | 青岛易邦生物工程有限公司 | 基因vii型新城疫病毒弱毒株及其应用 |
CN111575247A (zh) * | 2020-05-22 | 2020-08-25 | 浙江鼎持生物制品有限公司 | 一种新城疫嵌合病毒标记疫苗株及其构建方法和应用 |
CN111575247B (zh) * | 2020-05-22 | 2022-04-26 | 浙江鼎持生物制品有限公司 | 一种新城疫嵌合病毒标记疫苗株及其构建方法和应用 |
CN112877361A (zh) * | 2021-02-08 | 2021-06-01 | 青岛海华生物医药技术有限公司 | 一株重组新城疫病毒弱疫苗株及其构建方法 |
CN112961837A (zh) * | 2021-03-01 | 2021-06-15 | 武汉科前生物股份有限公司 | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 |
CN112961837B (zh) * | 2021-03-01 | 2022-07-12 | 武汉科前生物股份有限公司 | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 |
CN114574452A (zh) * | 2021-12-29 | 2022-06-03 | 扬州大学 | Hn基因易位构建重组新城疫疫苗候选株vii-hnf的方法及用途 |
CN114574452B (zh) * | 2021-12-29 | 2023-07-21 | 扬州大学 | Hn基因易位构建重组新城疫疫苗候选株vii-hnf的方法及用途 |
CN115896111A (zh) * | 2022-10-09 | 2023-04-04 | 青岛大学 | 一种抑制acsl4表达的小干扰rna及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101182494B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101182494B (zh) | 基因ⅶ型新城疫病毒致弱株a-ndv-ⅶ及其构建方法 | |
CN107815441A (zh) | 一种ⅱ型伪狂犬病毒减毒株及其制备方法和应用 | |
CN108456663B (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
CN102757942A (zh) | A型口蹄疫重组疫苗株及其制备方法和应用 | |
CN112094824B (zh) | 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用 | |
ES2342325T3 (es) | Un metodo para generar virus de la bursitis infecciosa a partir de transcritos sinteticos de arn. | |
CN109321534A (zh) | 一种重组基因viii型新城疫病毒弱毒株 | |
CN109321535A (zh) | 一种热稳定的新城疫病毒弱毒疫苗候选株 | |
CN113061587B (zh) | 一种抗原谱拓展o型口蹄疫病毒株及其构建方法和应用 | |
CN104480142A (zh) | 一种鸭瘟病毒基因缺失转移载体及其应用 | |
CN104593388B (zh) | 一种鲫鱼疱疹病毒病jdorf25疫苗及制备方法和应用 | |
CN113151191A (zh) | 鸽新城疫病毒vi-hz株及其应用 | |
CN102776156B (zh) | 基因Ⅵb亚型新城疫病毒致弱株ⅥbI4及其构建方法 | |
Yuan et al. | Surveillance and molecular characterization of Newcastle disease virus in seafowl from coastal areas of China in 2011 | |
CN102533676B (zh) | 新城疫病毒重组疫苗a-ndv-lx/i4及构建方法 | |
CN109402065B (zh) | 一种番鸭c亚型禽偏肺病毒弱毒株及其制备和应用 | |
CN105671002B (zh) | H9n2亚型禽流感病毒细胞高产疫苗株构建及应用 | |
CN106754765A (zh) | 一种新城疫病毒样颗粒、制备方法及其应用 | |
CN103074306A (zh) | 新城疫病毒rNDV-H52AH9及其构建方法和应用 | |
CN106085970B (zh) | 表达信号肽替换的h5亚型禽流感ha蛋白的重组新城疫耐热疫苗株及制备方法 | |
US10894081B2 (en) | Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof | |
Ghalyanchilangeroudi et al. | Genotyping of avian infectious bronchitis virus in Iran: Detection of D274 and changing in the genotypes rate | |
CN105802921B (zh) | 表达猪瘟病毒e2蛋白的重组伪狂犬病病毒变异株及其构建方法和应用 | |
CN106399267A (zh) | 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法 | |
CN107041951B (zh) | 重组口蹄疫三价灭活疫苗及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080521 Assignee: YANGZHOU UNI-BIO PHARMACEUTICAL Co.,Ltd. Assignor: Yangzhou University Contract record no.: 2017320000095 Denomination of invention: Genotype of Newcastle disease virus attenuated strain A-NDV- VII and its construction method Granted publication date: 20100908 License type: Common License Record date: 20170324 Application publication date: 20080521 Assignee: YEBIO BIOENGINEERING Co.,Ltd. OF QINGDAO Assignor: Yangzhou University Contract record no.: 2017320000094 Denomination of invention: Genotype of Newcastle disease virus attenuated strain A-NDV- VII and its construction method Granted publication date: 20100908 License type: Common License Record date: 20170324 Application publication date: 20080521 Assignee: JIANGSU NANNONG HI-TECH CO.,LTD. Assignor: Yangzhou University Contract record no.: 2017320000093 Denomination of invention: Genotype of Newcastle disease virus attenuated strain A-NDV- VII and its construction method Granted publication date: 20100908 License type: Common License Record date: 20170324 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 |